Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rhinocort AQUA in Pediatric Allergic Rhinitis
NCT00641693Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- Apr 2004
- Primary completion
- May 2005
- Modality
- Orthosteric Ligands
01
Overview
A Phase 2 trial of EPI-EE in allergic rhinitis (AR), sponsored by AstraZeneca. Started Apr 2004; status: completed.
02
Drugs
EPI-EE
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on NCT00641693.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00641693.